Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Daily News

Abciximab in ‘Short Supply’ Worldwide

Shelley Wood

April 13, 2018

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Industry News

Medicure Files Application for New AGGRASTAT® Product Format

May 11, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Industry News

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

July 22, 2015

News Daily News

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

April 03, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

April 03, 2015

Presentation

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

Presenter: Yaling Han

March 23, 2015

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Daily News

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

Caitlin E. Cox

May 03, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

Advertisement

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Abciximab in ‘Short Supply’ Worldwide

New Performance and Quality Metrics for STEMI and NSTEMI Care

FDA Approves New AGGRASTAT® Product Format

Medicure Files Application for New AGGRASTAT® Product Format

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content